![Eric S. Furfine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric S. Furfine
Direktör/Styrelseledamot på
INGENIA THERAPEUTICS INC.
Profil
Eric S.
Furfine currently works at Ingenia Therapeutics Inc., as Director and Mosaic Biosciences, Inc., as Chief Scientific Officer from 2025.
Dr. Furfine also formerly worked at GlaxoSmithKline LLC, as Director-Biochemical Analytical Pharmacology, Regeneron Pharmaceuticals, Inc., as Vice President-PreClinical Development, ImmuneXcite, Inc., as Chief Executive & Scientific Officer in 2016, Adnexus, as SVP-Research & Preclinical Development, and Sesen Bio, Inc., as Chief Scientific Officer from 2014 to 2016.
Dr. Furfine received his undergraduate degree from Washington University in St. Louis and doctorate degree from Brandeis University.
Aktiva positioner av Eric S. Furfine
| Företag | Position | Start |
|---|---|---|
| INGENIA THERAPEUTICS INC. | Direktör/Styrelseledamot | - |
Mosaic Biosciences, Inc.
 Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial research and development services | Teknisk/Vetenskaplig/F&U Direktör | - |
Tidigare kända positioner av Eric S. Furfine
| Företag | Position | Slut |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2016-02-05 |
ImmuneXcite, Inc.
 ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which develops monoclonal antibodies for cancer | Verkställande Direktör | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Företagsledare/Principal | - |
| REGENERON PHARMACEUTICALS, INC. | Företagsledare/Principal | - |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Teknisk/Vetenskaplig/F&U Direktör | - |
Eric S. Furfines utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
29
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mosaic Biosciences, Inc.
Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial research and development services | Commercial Services |
ImmuneXcite, Inc.
ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which develops monoclonal antibodies for cancer | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Ingenia Therapeutics Inc.
 Ingenia Therapeutics Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
